Ionization state and molecular docking studies for the macrophage migration inhibitory factor: the role of lysine 32 in the catalytic mechanism

The macrophage migration inhibitory factor (MIF) is a cytokine that is structurally similar to certain isomerases and for which multiple immune and catalytic roles have been proposed. Different catalytic activities have been reported for MIF, yet the exact mechanism by which MIF acts is not completely known. As a tautomerase, the enzyme uses a general acid–base mechanism of proton transfer in which the amino‐terminal proline has been shown to function as the catalytic base. We report the results of molecular docking simulations of macrophage migration inhibitory factor with three substrates, D‐dopachrome, L‐dopachrome methyl ester and p‐(hydroxyphenyl)pyruvate. Electrostatic pKa predictions were also performed for the free and complexed forms of the enzyme. The predicted binding mode of p‐(hydroxyphenyl)pyruvate is in agreement with the recently published X‐ray structure. A model for the binding mode of D‐dopachrome and L‐dopachrome methyl ester to MIF is proposed which offers insights into the catalytic mechanism of D‐dopachrome tautomerase activity of MIF. The proposed catalytic mechanism is further supported by the pKa predictions, which suggest that residue Lys32 acts as the general acid for the enzymatic catalysis of D‐dopachrome. Copyright © 2000 John Wiley & Sons, Ltd.

[1]  J. Bernhagen,et al.  Localization of Macrophage Migration Inhibitory Factor (MIF) to Secretory Granules within the Corticotrophic and Thyrotrophic Cells of the Pituitary Gland , 1995, Molecular medicine.

[2]  M. Fitzgerald,et al.  Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor. , 1998, Biochemistry.

[3]  Michael K. Gilson,et al.  The determinants of pK(a)s in proteins , 1996 .

[4]  T. Harris,et al.  Kinetic, stereochemical, and structural effects of mutations of the active site arginine residues in 4-oxalocrotonate tautomerase. , 1999, Biochemistry.

[5]  E Lolis,et al.  Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity. , 1999, Biochemistry.

[6]  M. Fitzgerald,et al.  Inactivation of 4-oxalocrotonate tautomerase by 2-oxo-3-pentynoate. , 1997, Biochemistry.

[7]  M. Gilson,et al.  Prediction of pH-dependent properties of proteins. , 1994, Journal of molecular biology.

[8]  J. Warwicker,et al.  Calculation of the electric potential in the active site cleft due to alpha-helix dipoles. , 1982, Journal of molecular biology.

[9]  L. R. Scott,et al.  Electrostatics and diffusion of molecules in solution: simulations with the University of Houston Brownian dynamics program , 1995 .

[10]  M. Gilson,et al.  Computing ionization states of proteins with a detailed charge model , 1996, J. Comput. Chem..

[11]  J. David.  Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[12]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .

[13]  M. Czisch,et al.  NMR characterization of structure, backbone dynamics, and glutathione binding of the human macrophage migration inhibitory factor (MIF) , 1996, Protein science : a publication of the Protein Society.

[14]  P. Kollman,et al.  An all atom force field for simulations of proteins and nucleic acids , 1986, Journal of computational chemistry.

[15]  W. Johnson,et al.  Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition. , 1999, Biochemistry.

[16]  Peter Björk,et al.  The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase , 1997, FEBS letters.

[17]  G A Petsko,et al.  Aromatic-aromatic interaction: a mechanism of protein structure stabilization. , 1985, Science.

[18]  R. Kleemann,et al.  Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. , 1998, Journal of molecular biology.

[19]  L. Pannell,et al.  Enzyme Activity of Macrophage Migration Inhibitory Factor toward Oxidized Catecholamines* , 1999, The Journal of Biological Chemistry.

[20]  R. Bucala,et al.  An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J M Briggs,et al.  Docking of 4-oxalocrotonate tautomerase substrates: implications for the catalytic mechanism. , 1999, Biopolymers.

[22]  I. Tanaka,et al.  Molecular cloning of human D-dopachrome tautomerase cDNA: N-terminal proline is essential for enzyme activation. , 1998, Biochemical and biophysical research communications.

[23]  C. Tanford,et al.  Theory of Protein Titration Curves. I. General Equations for Impenetrable Spheres , 1957 .

[24]  B. Bloom,et al.  Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity , 1966, Science.

[25]  Elias Lolis,et al.  Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor , 1998, The EMBO journal.

[26]  A. Mildvan,et al.  4-Oxalocrotonate tautomerase: pH dependence of catalysis and pKa values of active site residues. , 1996, Biochemistry.

[27]  J. Bernhagen,et al.  MIF as a glucocorticoid-induced modulator of cytokine production , 1995, Nature.

[28]  M. Karplus,et al.  pKa's of ionizable groups in proteins: atomic detail from a continuum electrostatic model. , 1990, Biochemistry.

[29]  K. Tracey,et al.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia , 1993, Nature.

[30]  Alexander B. Taylor,et al.  Crystal structure of 4-oxalocrotonate tautomerase inactivated by 2-oxo-3-pentynoate at 2.4 A resolution: analysis and implications for the mechanism of inactivation and catalysis. , 1998, Biochemistry.

[31]  J. Bernhagen,et al.  Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Gilson.  Modeling protonation equilibria in biomolecules , 1997 .

[33]  R. Bucala,et al.  Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. , 1997, Biochemistry.

[34]  R. Bucala,et al.  The Immunoregulatory Mediator Macrophage Migration Inhibitory Factor (MIF) Catalyzes a Tautomerization Reaction , 1996, Molecular medicine.

[35]  L. M. Kaiser,et al.  Purification and properties of the apple fruit ethylene-forming enzyme. , 1993, Biochemistry.